CSL Seqirus UK Limited articles
Meet D, one of CSL Seqirus’ Senior Regional Account Managers by day and international lacrosse coach by night.
His network of health care system accounts across Northern Texas, Oklahoma and New Mexico know him as D, their Senior Regional Account Manager, but he also goes by Coach D.
Why? Because outside of supporting his region’s vaccination needs at CSL Seqirus, leading influenza vaccines provider, you’ll find him coaching the Pu
Eric Monticell
Infectious diseases like influenza can be threats to public health and our economy.
At the OPTIONS XI for the Control of Influenza conference, leading influenza vaccines provider CSL Seqirus, joined academic, government, research and industry stakeholders to discuss and learn more about influenza and its impact.
Below, CSL Seqirus shared additional insights into topics of interest to the influenza community, helping to shed
Eric Monticello
Misinformation can have a profound impact on public health, experts say that education might be the key to combating it.
According to the World Health Organization (WHO), immunization saves millions of lives each year. But given that many are still hesitant to get vaccinated for COVID-19, it is apparent that we are amidst an ‘infodemic’.
“We’
Eric Monticello
School is back in session, here’s what you need to know to help keep your family protected from flu.
Influenza can be a real burden. It can spread rapidly between children and their families to have a significant impact on quality of life and disruption of usual activities: resulting in missed school days and for caregivers, missed work and
Eric Monticello
In 2022, flu cases in Australia have spiked earlier and with more cases this season than the previous five for the same time period. Experts discuss global implications of the surge.
“Influenza is definitely back in the Southern Hemisphere,” said Professor Ian Barr, Deputy Director of The World Health Organization Collaborating Centre for Reference and Research on Influenza,
CSL Seqirus delivered a record 135 million doses of flu vaccines globally last year, here’s how we make such a feat happen.
Influenza vaccine manufacturing is an intricate and complex process that culminates in the summer months, when U.S. flu vaccine manufacturers receive regulatory approval from the FDA for the season’s vaccines. The manufacturers then prepare to distribute millions of doses to health care providers all over the country. That proce
Tab Lassiter – an employee of global vaccines leader CSL Seqirus – is about to receive a second transplant in an ongoing battle with a heart condition. He shares his story to explain why it’s critical to spread the word about heart health.
Tab Lassiter once spent eight months resting anxiously in a hospital bed with
Eric Monticello
Why we can’t overlook influenza in the midst of the ongoing COVID-19 pandemic.
In many parts of the world, public health authorities are lifting social distancing, mask wearing and other COVID-19 mitigation measures in response to subsiding or stabilizing infection rates. But as daily life slowly returns to normal – and in the absence of an effective call to action on getting an annual influenza vaccine – we must not let our guard down amidst t
Eric Monticello
Influenza is constantly mutating. 70 years ago, the World Health Organization set up a surveillance network to protect people from its threat.
Making influenza vaccines that can help protect against viruses that threaten human health isn’t a simple process. It requires the cooperation between influenza vaccine manufacturers like Seqirus, and the World Health Organization’s (WHO) 158 laboratories in 127 countries and 7 collaborating centers that compr
Eric Monticello